These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 14667132)

  • 21. Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status.
    Szulc P; Hofbauer LC; Heufelder AE; Roth S; Delmas PD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3162-5. PubMed ID: 11443182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women.
    Rogers A; Saleh G; Hannon RA; Greenfield D; Eastell R
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4470-5. PubMed ID: 12364420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in the serum growth factors and osteoprotegerin after bone marrow transplantation: impact on bone and mineral metabolism.
    Baek KH; Lee WY; Oh KW; Kim HS; Han JH; Kang MI; Cha BY; Lee KW; Son HY; Kang SK; Kim CC
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1246-54. PubMed ID: 15001618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative normal level of parathyroid hormone signifies an early and mild form of primary hyperparathyroidism.
    Bergenfelz A; Lindblom P; Lindergård B; Valdemarsson S; Westerdahl J
    World J Surg; 2003 Apr; 27(4):481-5. PubMed ID: 12658497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin K2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG).
    Sasaki N; Kusano E; Takahashi H; Ando Y; Yano K; Tsuda E; Asano Y
    J Bone Miner Metab; 2005; 23(1):41-7. PubMed ID: 15616893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of parathyroid hormone measurements after surgery for primary hyperparathyroidism.
    Yen TW; Wilson SD; Krzywda EA; Sugg SL
    Surgery; 2006 Oct; 140(4):665-72; discussion 672-4. PubMed ID: 17011915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of Parathyroidectomy on Bone Metabolism and Bone Pain in Patients with Secondary Hyperparathyroidism.
    Schneider R; Steinmetz C; Karakas E; Bartsch DK; Schlosser K
    Eur Surg Res; 2018; 59(1-2):35-47. PubMed ID: 29393259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone and Mineral Metabolism Phenotypes in MEN1-Related and Sporadic Primary Hyperparathyroidism, before and after Parathyroidectomy.
    Marini F; Giusti F; Cioppi F; Maraghelli D; Cavalli T; Tonelli F; Brandi ML
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parathyroidectomy for primary hyperparathyroidism induces positive uncoupling and increases bone mineral density in cancellous bones.
    Abe Y; Ejima E; Fujiyama K; Kiriyama T; Ide A; Sera N; Tominaga T; Ashizawa K; Yokoyama N; Eguchi K
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):203-9. PubMed ID: 10671948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcimimetics versus parathyroidectomy for treatment of primary hyperparathyroidism: retrospective chart analysis of a prospective database.
    Keutgen XM; Buitrago D; Filicori F; Kundel A; Elemento O; Fahey TJ; Zarnegar R
    Ann Surg; 2012 May; 255(5):981-5. PubMed ID: 22470074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating amounts of osteoprotegerin and RANK ligand: genetic influence and relationship with BMD assessed in female twins.
    Abrahamsen B; Hjelmborg JV; Kostenuik P; Stilgren LS; Kyvik K; Adamu S; Brixen K; Langdahl BL
    Bone; 2005 Apr; 36(4):727-35. PubMed ID: 15781001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteoprotegerin serum levels in children with type 1 diabetes: a potential modulating role in bone status.
    Galluzzi F; Stagi S; Salti R; Toni S; Piscitelli E; Simonini G; Falcini F; Chiarelli F
    Eur J Endocrinol; 2005 Dec; 153(6):879-85. PubMed ID: 16322394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationships between the changes of serum levels of OPG and RANKL with age, menopause, bone biochemical markers and bone mineral density in Chinese women aged 20-75.
    Liu JM; Zhao HY; Ning G; Zhao YJ; Chen Y; Zhang Zh; Sun LH; Xu MY; Chen JL
    Calcif Tissue Int; 2005 Jan; 76(1):1-6. PubMed ID: 15455183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre- and postoperative bone metabolism of primary hyperparathyroidism.
    Suzuki S; Fukushima T; Ami H; Asahi S; Onogi H; Nakamura I; Tsuchiya A; Takenoshita S
    Biomed Pharmacother; 2000 Jun; 54 Suppl 1():90s-96s. PubMed ID: 10915001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients.
    Seminari E; Castagna A; Soldarini A; Galli L; Fusetti G; Dorigatti F; Hasson H; Danise A; Guffanti M; Lazzarin A; Rubinacci A
    HIV Med; 2005 May; 6(3):145-50. PubMed ID: 15876279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation.
    Ma YL; Cain RL; Halladay DL; Yang X; Zeng Q; Miles RR; Chandrasekhar S; Martin TJ; Onyia JE
    Endocrinology; 2001 Sep; 142(9):4047-54. PubMed ID: 11517184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in bone mass and metabolism after surgery for primary hyperparathyroidism.
    Garton M; Martin J; Stewart A; Krukowski Z; Matheson N; Robins S; Loveridge N; Reid D
    Clin Endocrinol (Oxf); 1995 May; 42(5):493-500. PubMed ID: 7621568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of changes in bone density and biochemical parameters after parathyroidectomy in primary hyperparathyroidism.
    Nakaoka D; Sugimoto T; Kobayashi T; Yamaguchi T; Kobayashi A; Chihara K
    Endocr J; 2000 Jun; 47(3):231-7. PubMed ID: 11036865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased serum osteoprotegerin values in long-lived subjects: different effects of inflammation and bone metabolism.
    Mazziotti G; Amato G; Sorvillo F; Piscopo M; Rizzo MR; Lalli E; Iride L; Cioffi M; Molinari AM; Paolisso G; Carella C
    Eur J Endocrinol; 2006 Mar; 154(3):373-7. PubMed ID: 16498049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of parathyroidectomy on osteopontin and undercarboxylated osteocalcin in patients with primary hyperparathyroidism.
    Maser RE; Lenhard MJ; Pohlig RT; Balagopal PB; Abdel-Misih R
    Endocr Res; 2018 Feb; 43(1):21-28. PubMed ID: 28937873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.